当前位置: X-MOL首页全球导师 国内导师 › 施裕丰

个人简介

2019/8- 特聘教授、博士生导师 同济大学医学院/上海市第十人民医院 2015/7-2019/8 助理研究员,斯隆-凯特琳纪念医院癌症中心,脑瘤中心 2011/9-2015/6 讲师, 德克萨斯州西南医学中心发育生物学系 2007/11-2011/8 博士后,康内尔大学威尔分子和细胞研究所 2002/9-2007/7 博士,中国科学院上海生命科学研究院细胞生物学 1998/9-2002/6 学士,南开大学生物学系 施裕丰教授在细胞和肿瘤生物学研究领域造诣深厚。作为第一作者在Nature、Cell、Nature Immunology等顶级权威杂志上发表代表性论文多篇,总影响因子超过100。申请1项国际发明专利。曾以共同主持人身份主持1项美国纪念斯隆-凯特琳癌症中心药物研究项目,参与2 项美国国家健康研究院(NIH)研究项目和3 项德克萨斯州肿瘤研究院项目。其工作成果曾获得全国百篇优秀论文、中国科学院百篇和谈家桢基金生命科学九源奖学金等一系列奖项。

研究领域

线粒体和肿瘤 (mitochondria and cancer) 线粒体代谢重编程是肿瘤细胞的基本特征之一。最近的工作表明:肿瘤中一群具有高干细胞特性的肿瘤细胞所含线粒体显著区别于一般正常体细胞的线粒体,并且这类肿瘤细胞非常依赖其线粒体功能而存活。实验室现下的主要工作是研究神经胶质瘤干细胞对线粒体功能依赖的分子机制和神经胶质瘤线粒体上可成药靶点。

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Shi Y., Lim SK., Liang Q., Iyer S., Wang H., Wang Z., Xie X., Chen Y., Tabar V., Glutin P., Williams N., De Brabander JK., and Parada LF. A novel oxidative phosphorylation inhibitor targets glioblastoma. Nature, 2019 Mar; 567(7748):341-346. 第一作者,文章在Nature Review Drug Discovery 和Nature Review Cancer 上被亮点点评。 Shi, Y., Feng, Y., Kang, J., Liu, C., Li, Z., Li, D., Cao, W., Bi, E., Zang, L., Lu, C., Zhang, J., and Pei, G. Critical regulation of CD4+ T cell survival and autoimmunity by beta-Arrestin 1. Nat Immnol. 2007 8(8):817-824. 第一作者 Kang, J*., Shi, Y*., Xiang, B*., Qu, B., Su, W., Zhu, M., Zhang, M., Bao, G., Wang, F., Zhang, X., et al. A nuclear function of beta-arrestin1 in GPCR signaling regulation of histone acetylation and gene transcription. Cell 2005 123, 833-847.1. (*These authors contributed equally to this paper) 共同一作 Shi, Y., Lim, SK., Parada, LF. The soft underbelly of tumor cells. Cell research, 2014 24:910–911 第一作者 Shi, Y., Stefan, C., Emr, S. Two novel WD40 domain-containing protein, Ere1 and Ere2, function in the retromer-mediated endosomal recycling pathway. MBoC, 2011 Nov;22(21):4093-107. 第一作者 Zilai Wang, Daochun Sun, Yu-Jung Chen, Xuanhua Xie, Yufeng Shi, Viviane Tabar, Cameron W. Brennan Tejus Bale, Chenura D. Jayewichreme, Dan R. Laks, Sheila Alcantara Llaguno and Parada LF. Cell lineage-Based Stratification for glioblastoma. Cancer Cell, 2020 Sep; Shichao Huang2#*, Yu’e Liu1#, Yanan Zhang3#, Ru Zhang1, ChengJie Zhu1, Lihong Fan1 , Gang Pei1,2, Bo Zhang3 *, Yufeng Shi * Baicalein inhibits SARS-CoV-2/VSV replication with interfering mitochondrial oxidative phosphorylation in a mPTP dependent manner,Signal Transduction and Targeted Therapy, 2020 通讯作者 Yu’e Liu#, Yufeng Shi* Mitochondria as a target in cancer treatment. Medcomm,2020.9.1 (2):129-139 通讯作者 Ming Li # , Bingjie Hao # , Menghuan Zhang # , Russel J Reiter , Shumeng Lin , Tiansheng Zheng , Xiangyun Chen , Yanbei Ren , Liduo Yue , Baigenzhin Abay , Guojie Chen , Xiao Xu 1, Yufeng Shi* , Lihong Fan* Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development. Signal Transduction and Targeted Therapy, 2021 共同通讯作者 Yu’e Liu#, Chao Chen#, Xinye Wang, Yihong Sun, Juxiang Chen*, Yufeng Shi*, An Epigenetic Role of Mitochondria in Cancer, Cells, 2022, 11(16), 2518; 通讯作者 Changqing Wu #1, Yu'e Liu #1, Wenju Liu# 2, Tianhui Zou# 3, Shaojuan Lu 1, Chengjie Zhu 1, Le He 1, Jie Chen 1, Lan Fang 1, Lin Zou 4, Ping Wang 1, Lihong Fan 5, Hongxiang Wang 6, Han You 7, Juxiang Chen* 6, Jing-Yuan Fang* 3, Cizhong Jiang *2, Yufeng Shi* 1 2 8 NNMT-DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation Inhibition Advanced Science 2022 DOI: 10.1002/advs.202202642 通讯作者 Yu’e Liu, Yufeng Shi, Ping Wang*, Functions of glutaminyl cyclase and its isoform in diseases Visualized Cancer Medicine 共同作者 Yu’e Liu#*, Yihong Sun#, Xiaoyun Shi#, Xi Chen, Yi Wang, Yufeng Shi*, An Overview: The Diversified Role of Mitochondria in Cancer Metabolism. International Journal of Biological Sciences 2023 通讯作者 Yue’Liu#, Yanjin Wang#, Yanrong Yang#,, Linjun Weng, Qi Wu, Jin Zhang, Pengcheng Zhao, Lan Fang*, Yufeng Shi*, Ping Wang* Emerging phagocytosis checkpoints in cancer immunotherapy. Signal Transduction and Targeted Therapy, 2023共同通讯 Yue’Liu#, Weng Linjun#, Wang Yanjin#,, Qi Wu, Jin Zhang, Pengcheng Zhao, Yufeng Shi*, Ping Wang*, Lan Fang*, Emerging phagocytosis checkpoints in cancer immunotherapy. Journal of Advanced Research, 2023共同通讯 Yuanpei Li #, Xiaoniu He # ,Xiao Lu , Zhicheng Gong , Qing Li , Lei Zhang , Ronghui Yang , Chengyi Wu , Jialiang Huang , Jiancheng Ding , Yaohui He , Wen Liu , Ceshi Chen , Bin Cao , Dawang Zhou , Yufeng Shi , Juxiang Chen , Chuangui Wang, Shengping Zhang, WangJian Zhang , Jing Ye , Han You * METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions Nature Communications 2022 共同作者 Jin-Zhu Wang 1, Hong Zhu 1, Pu You 2, Hui Liu 1, Wei-Kang Wang 1, Xiaojuan Fan 3, Yun Yang 3, Keren Xu 4, Yingfeng Zhu 5, Qunyi Li 6, Ping Wu 7, Chao Peng 7, Catherine Cl Wong 7, Kaicheng Li 2, Yufeng Shi 8, Nu Zhang 9, Xiuxing Wang 10, Rong Zeng 4, Ying Huang 11, Liusong Yang 12, Zefeng Wang 3, Jingyi Hui 1 Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway The Journal of Clinical Investigation 2022.共同作者 Chao Chen#, Yu’e Liu#, Hongxiang#, Wang, Xu Zhang, Yufeng Shi*, Juxiang Chen*, FOXO1-miR-506 axis promotes chemosensitivity to temozolomide and suppresses invasiveness in glioblastoma through a feedback loop of FOXO1/miR-506/ETS1/FOXO1 Journal of Zhejiang University-SCIENCE B,2023 Aug 15;24(8):698-710 共同通讯 Yu’e Liu1#*, Shaojuan Lu1#, Yihong Sun1#, Shibo Yu2, Xi Chen3, Lei-lei Wu4, Yufeng Shi*, Kaijun Zhao* Deciphering the role of QPCTL in glioma progression and cancer immunotherapy Frontiers in Immunology, 2023 Mar 29;14:1166377. 共同通讯 Yu’e Liu#, Shu Zhao#, Fei Wang, Chengjie, Zhu, Le He, Jie Chen, Yufeng Shi, Kaijun Zhao*, Vimentin promotes glioma progression and maintains glioma cell oxidative phosphorylation inhibition Cellular Oncology 2023.8

推荐链接
down
wechat
bug